News
Developing new drugs to treat illnesses has typically been a slow and expensive process. However, a team of researchers at ...
Isomorphic Labs, which uses artificial intelligence technologies for drug discovery, has raised $600 million in its first ...
While AI offers remarkable efficiency, the pharmaceutical industry must address concerns about “black box” predictions – AI ...
The London-based business – which launched in 2021 – will use the funds to further its research, expand its team and continue ...
Isomorphic Labs says it is advancing drug design programs across multiple therapeutic areas and drug modalities. These ...
The U.S. Food and Drug Administration is replacing animal testing with human-relevant methods, including artificial ...
The subsidiary of Google parent Alphabet plans to use its first round of external funding to boost its ...
New center will use cutting-edge AI to accelerate the creation of life-saving medicines AI Small Molecule Drug Discovery ...
The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital ...
The Food and Drug Administration (FDA) announced Thursday it plans to phase out animal testing requirements for biological ...
AI drug discovery firm Isomorphic Labs has completed the company’s first external funding round since its 2021 founding ...
Google spinoff Isomorphic Labs raised $600 million in its first external funding round as the company looks to apply ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results